BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

787 related articles for article (PubMed ID: 8986437)

  • 1. Gene therapy of spontaneous canine melanoma and feline fibrosarcoma by intratumoral administration of histoincompatible cells expressing human interleukin-2.
    Quintin-Colonna F; Devauchelle P; Fradelizi D; Mourot B; Faure T; Kourilsky P; Roth C; Mehtali M
    Gene Ther; 1996 Dec; 3(12):1104-12. PubMed ID: 8986437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local immunotherapy of spontaneous feline fibrosarcomas using recombinant poxviruses expressing interleukin 2 (IL2).
    Jourdier TM; Moste C; Bonnet MC; Delisle F; Tafani JP; Devauchelle P; Tartaglia J; Moingeon P
    Gene Ther; 2003 Dec; 10(26):2126-32. PubMed ID: 14625567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo tumor transfection with superantigen plus cytokine genes induces tumor regression and prolongs survival in dogs with malignant melanoma.
    Dow SW; Elmslie RE; Willson AP; Roche L; Gorman C; Potter TA
    J Clin Invest; 1998 Jun; 101(11):2406-14. PubMed ID: 9616212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suicide gene and cytokines combined nonviral gene therapy for spontaneous canine melanoma.
    Finocchiaro LM; Fiszman GL; Karara AL; Glikin GC
    Cancer Gene Ther; 2008 Mar; 15(3):165-72. PubMed ID: 18219342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between initial and long-term responses of spontaneous pet animal tumors to heat and radiation or radiation alone.
    Dewhirst MW; Sim DA; Wilson S; DeYoung D; Parsells JL
    Cancer Res; 1983 Dec; 43(12 Pt 1):5735-41. PubMed ID: 6640525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination surgery and nonviral interleukin 2 gene therapy for head and neck cancer.
    Li D; Jiang W; Bishop JS; Ralston R; O'Malley BW
    Clin Cancer Res; 1999 Jun; 5(6):1551-6. PubMed ID: 10389944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine-enhanced vaccine and suicide gene therapy as surgery adjuvant treatments for spontaneous canine melanoma.
    Finocchiaro LM; Glikin GC
    Gene Ther; 2008 Feb; 15(4):267-76. PubMed ID: 18033308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I clinical trial with IL-2-transfected xenogeneic cells administered in subcutaneous metastatic tumours: clinical and immunological findings.
    Tartour E; Mehtali M; Sastre-Garau X; Joyeux I; Mathiot C; Pleau JM; Squiban P; Rochlitz C; Courtney M; Jantscheff P; Herrmann R; Pouillart P; Fridman WH; Dorval T
    Br J Cancer; 2000 Dec; 83(11):1454-61. PubMed ID: 11076653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-tumoral gene delivery of feIL-2, feIFN-gamma and feGM-CSF using magnetofection as a neoadjuvant treatment option for feline fibrosarcomas: a phase-I study.
    Jahnke A; Hirschberger J; Fischer C; Brill T; Köstlin R; Plank C; Küchenhoff H; Krieger S; Kamenica K; Schillinger U
    J Vet Med A Physiol Pathol Clin Med; 2007 Dec; 54(10):599-606. PubMed ID: 18045346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant therapy for melanoma in dogs: results of randomized clinical trials using surgery, liposome-encapsulated muramyl tripeptide, and granulocyte macrophage colony-stimulating factor.
    MacEwen EG; Kurzman ID; Vail DM; Dubielzig RR; Everlith K; Madewell BR; Rodriguez CO; Phillips B; Zwahlen CH; Obradovich J; Rosenthal RC; Fox LE; Rosenberg M; Henry C; Fidel J
    Clin Cancer Res; 1999 Dec; 5(12):4249-58. PubMed ID: 10632367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-2 plasmid electroporation: from preclinical studies to phase I clinical trial.
    Horton HM; Lalor PA; Rolland AP
    Methods Mol Biol; 2008; 423():361-72. PubMed ID: 18370214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient inducation of local and systemic antitumor immune response by liposome-mediated intratumoral co-transfer of interleukin-2 gene and interleukin-6 gene.
    Cao X; Wang Q; Ju DW; Tao Q; Wang J
    J Exp Clin Cancer Res; 1999 Jun; 18(2):191-200. PubMed ID: 10464706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of hepatocellular carcinoma by transfecting interleukin-12 and interleukin-2 fusion gene intrasplenically, an experimental study].
    Yang JH; Fan RF; Qian QJ; You TG; Xue HB; Su CQ; Cao HF; Wu MC
    Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):740-3. PubMed ID: 12899748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypofractionated radiation therapy for the treatment of malignant melanoma and squamous cell carcinoma in dogs and cats].
    Kinzel S; Hein S; Stopinski T; Koch J; Buecker A; Treusacher HP; Schmachtenberg A; Jansen T; Eble M; Küpper W
    Berl Munch Tierarztl Wochenschr; 2003; 116(3-4):134-8. PubMed ID: 12680280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melanoma differentiation-associated gene-7 (mda-7)/interleukin (IL)-24 induces anticancer immunity in a syngeneic murine model.
    Miyahara R; Banerjee S; Kawano K; Efferson C; Tsuda N; Miyahara Y; Ioannides CG; Chada S; Ramesh R
    Cancer Gene Ther; 2006 Aug; 13(8):753-61. PubMed ID: 16543916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different efficacy of in vivo herpes simplex virus thymidine kinase gene transduction and ganciclovir treatment on the inhibition of tumor growth of murine and human melanoma cells and rat glioblastoma cells.
    Berenstein M; Adris S; Ledda F; Wolfmann C; Medina J; Bravo A; Mordoh J; Chernajovsky Y; Podhajcer OL
    Cancer Gene Ther; 1999; 6(4):358-66. PubMed ID: 10419054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine-enhanced vaccine and suicide gene therapy as surgery adjuvant treatments for spontaneous canine melanoma: 9 years of follow-up.
    Finocchiaro LM; Glikin GC
    Cancer Gene Ther; 2012 Dec; 19(12):852-61. PubMed ID: 23059870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
    O'Malley BW; Li D; McQuone SJ; Ralston R
    Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine-enhanced vaccine and interferon-β plus suicide gene as combined therapy for spontaneous canine sarcomas.
    Finocchiaro LM; Villaverde MS; Gil-Cardeza ML; Riveros MD; Glikin GC
    Res Vet Sci; 2011 Oct; 91(2):230-4. PubMed ID: 21300385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of prognostic factors and patterns of failure in dogs with malignant oral tumors treated with megavoltage irradiation.
    Théon AP; Rodriguez C; Madewell BR
    J Am Vet Med Assoc; 1997 Mar; 210(6):778-84. PubMed ID: 9074679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.